CBD for neurosis and anxiety: how much to take, when it helps, and what to expect

Anxiety disorders are the most common mental disorders in the world: in 2021, 359 million people lived with them, and treatment is received by about one in four of them (WHO). It's no wonder that people seek support outside the office and that CBD has topped that list. The problem is that the popular message "take a few drops, it will calm you down" diverges from the data. The studies cited in advertisements administered 300 mg or 600 mg at a time, and the largest systematic review found no effect in seven out of ten observations. This text shows what exactly was measured, what doses were reported in the protocols, why increasing portions can negate the effect, and at what point the supplement stops being the answer.

KEY INFORMATION
• A systematic review of 87 studies (Kwee et al., Journal of Psychopharmacology, 2022): in 70.3% of observations, CBD did not affect anxiety.
• Inverted U curve: a dose of 300 mg reduced anxiety, while 150 mg and 600 mg did not differ from placebo (Linares et al., 2019).
• Research protocols for situational anxiety recommend 300-600 mg at once, which is over a hundred drops of 5% oil.
• Neurosis is a common term for anxiety disorders. They are treated with psychotherapy and pharmacotherapy, not supplements.

What is neurosis and how are anxiety disorders treated?

Neurosis is a common term for anxiety disorders, which include generalized anxiety, social phobia, and panic attacks. Modern psychiatry treats them with cognitive-behavioral therapy and SSRIs. The WHO reports that in 2021, 359 million people lived with such a diagnosis, and about one-quarter of them receive help.

Each of these diagnoses has separate criteria in the ICD-11 and DSM-5 classifications, but the mechanism is similar. The limbic system reacts to an objectively neutral stimulus as if it were a threat, triggering a full stress response. Hence the physical symptoms, such as palpitations and muscle tension, as well as difficulty falling asleep. The WHO does not recommend benzodiazepines as a first-line treatment, citing the risk of dependence and limited long-term effectiveness.

This framework is significant for the rest of the text. A supplement is not an alternative to therapy or medication prescribed by a psychiatrist. It can at most be an addition, and one that the attending physician is aware of. If you turn to CBD because therapy is expensive and the wait for a psychiatrist is long, that’s understandable, but it doesn’t change what the data shows.

How could CBD affect anxiety?

CBD does not act on GABA-A receptors, so its mechanism differs from that of benzodiazepines. Three pathways have been described in animal models and imaging studies: stimulation of the serotonin receptor 5-HT1A, inhibition of limbic structures, and increased levels of anandamide by inhibiting the FAAH enzyme. These hypotheses are well-documented in animals, but much less so in humans.

Review Blessing i in. (Neurotherapeutics, 2015) collected animal and human evidence, then summarized it cautiously: preclinical data strongly support the anxiolytic effect of a single dose, while there is little research on chronic administration. This statement from a decade ago still holds true, as since then, there have mainly been case series rather than large randomized studies.

In humans, the mechanism was approached most closely Crippa i in. (Journal of Psychopharmacology, 2011). Ten previously untreated patients with generalized social phobia received a single dose of 400 mg of CBD or placebo, and cerebral blood flow was measured using SPECT. After CBD, subjective anxiety decreased, and blood flow changed in the hippocampus and parahippocampal gyrus. This is a small sample size and a preliminary study, so treat this result as a lead, not as proof.

What do clinical studies show about CBD and anxiety?

Individual studies appear promising, but the overall picture is much worse. A systematic review Kwee i in. (Journal of Psychopharmacology, 2022) included 87 studies and showed that in 70.3% of observations, CBD did not affect anxiety. The authors stated outright that formulating a dosage recommendation is currently not possible.

On the side of positive results, there are three studies. Bergamaschi i in. (Neuropsychopharmacology, 2011) they administered 600 mg of CBD or placebo to 24 untreated patients with social phobia one and a half hours before a simulated public speaking event. The group receiving CBD reported less anxiety and discomfort during the speech. Shannon i in. (Permanente Journal, 2019) they described 72 patients from a psychiatric clinic who received CBD as an addition to their ongoing treatment at an average dose of 25 mg per day. Anxiety scores decreased in the first month for 57 individuals, or 79.2%, and sleep scores improved for 66.7%. Elms i in. (Journal of Alternative and Complementary Medicine, 2019) they followed 11 PTSD patients for eight weeks, noting a 28% decrease in the average PCL-5 score.

Two of these three studies are retrospective case series without a control group and without placebo. The patients in the studies by Shannon and Elms continued their psychiatric treatment throughout, so improvements cannot be attributed solely to CBD. Comparing these numbers with Kwee's review provides a realistic picture: the effect can be visible, but it is neither certain, nor large, nor reproducible in every protocol.

Why does a higher dose of CBD not mean a better effect?

Because the dose-response curve has the shape of an inverted U. In a study Linares i in. (Brazilian Journal of Psychiatry, 2019) 57 healthy men received either placebo or CBD at doses of 150 mg, 300 mg, or 600 mg before a simulated speech. Only the 300 mg dose reduced anxiety. The other doses did not differ from placebo.

The same pattern appeared earlier in natural conditions. Zuardi i in. (Frontiers in Pharmacology, 2017) they studied 60 individuals speaking before a real audience, administering placebo, 1 mg clonazepam, or CBD at doses of 100 mg, 300 mg, or 900 mg. Anxiety after the speech decreased in the clonazepam group and in the 300 mg CBD group. The 100 mg and 900 mg doses did not work, even though one of them was three times higher than the effective dose.

The conclusion is uncomfortable for supplement marketing. The principle of 'if a little helps, more will help more' does not apply to CBD, and exceeding the window of effectiveness can extinguish the effect. We have noticed that individuals who feel nothing after a week instinctively reach for an increase in dosage. In light of both studies, this is a move that may work against them.

There is one more caveat. Both studies measured situationally induced anxiety, once, in healthy individuals or those with social phobia. No one has checked where the window of effectiveness lies after several months of daily use, as such data simply does not exist.

How do the doses from studies compare to the drops from the bottle?

They differ by an order of magnitude. The effective single dose in anxiety studies is 300 mg of CBD, while a 10 ml bottle of 5% oil contains 500 mg. One dose from the research protocol would use more than half the bottle, which is about 150 drops. A typical supplemental dose falls within the range of 10-25 mg.

Therefore, transferring research results to daily supplementation is an overreach. When the text references Bergamaschi and then suggests five drops in the next sentence, it describes two completely different interventions. Review Millar i in. (British Journal of Clinical Pharmacology, 2019) reviewed 35 clinical studies and found doses ranging from below 1 to 50 mg per kilogram of body weight per day. For a person weighing 70 kg, the lower end of this range is around 70 mg per day.

This does not mean that smaller doses are worthless. Shannon's series worked with an average of 25 mg per day and noted improvements, albeit without a control group. This means that evidence from a study on 300 mg does not automatically transfer to 20 mg. Supplement sellers regularly make this leap, leaving the reader with expectations that the product cannot fulfill. We described practical conversions to drops separately in the text Dosage of CBD: how many drops of oil to take.

What to realistically expect and when is a doctor needed?

A realistic scenario is a slight reduction in tension during the day and easier falling asleep, while some individuals may experience no change at all. CBD will not stop a panic attack, will not cure phobias, and cannot replace psychotherapy for obsessive-compulsive disorder. The review by Kwee et al. from 2022 shows that the lack of effect is the most common outcome.

Conversations with users reveal a recurring description: not so much the disappearance of anxiety, but rather reduced reactivity to minor stimuli. People talk about a calming of internal noise, not about shutting down emotions. This is consistent with pharmacology, as CBD does not act on GABA-A and does not provide sedation comparable to a tranquilizer. In Zuardi's study, clonazepam was found to be significantly more sedative than CBD at a dose of 300 mg.

Schedule an appointment with a psychiatrist or psychologist if anxiety limits work and relationships, if panic attacks recur, if suicidal thoughts arise, or if you turn to alcohol to calm down. These are not situations where a supplement is appropriate. We separately described anxiety about public speaking and contact with people in the text about CBD and social phobia.

If you still want to try, frame it as a test. Set one dose, maintain it for four weeks, and record your anxiety level on a scale from 1 to 10 once a day at the same time. Without such a record, you won't be able to distinguish the product's effects from natural mood fluctuations, which can be significant in anxiety disorders.

How does CBD differ from benzodiazepines and what about interactions?

It differs in mechanism and risk profile. Benzodiazepines enhance GABA inhibition and act quickly, but lead to tolerance and physical dependence. The WHO in the 2018 report from the Expert Committee on Drug Dependence stated that in humans, CBD does not show effects indicating potential for abuse or dependence.

The risks associated with benzodiazepines are well documented. A case-control study Billioti de Gage i in. (BMJ, 2014) included 1796 patients with Alzheimer's disease and 7184 control subjects and showed an odds ratio of 1.51 for those who had used these medications in the past. The strength of the association increased with the duration of exposure, and no association was found with exposure of less than 91 daily doses. This is an argument for caution, not proof of causality.

The biggest practical problem with CBD is interactions. It inhibits the CYP3A4 and CYP2C19 enzymes, which metabolize many psychiatric medications, potentially increasing their concentration in the blood. Geffrey i in. (Epilepsia, 2015) they measured this in children treated with clobazam: the concentration of the drug increased by an average of 60%, and its active metabolite by 500%. Brown i Winterstein (Journal of Clinical Medicine, 2019) they noted that adverse effects occurred in nearly half of those using CBD and depended on the dose.

The practical conclusion is simple. If you are taking an antidepressant, anticonvulsant, or benzodiazepine, inform your doctor about CBD before introducing it. A complete overview can be found in the text about interakcjach CBD z lekami.

Frequently Asked Questions

Does CBD help with neurosis and anxiety disorders?

Sometimes, but less often than advertising suggests. A systematic review of 87 studies (Kwee i in., 2022) found no effect of CBD on anxiety in 70.3% of observations. Individual protocols with a dose of 300 mg yielded positive results. CBD does not replace psychotherapy or medications.

How much CBD to take for anxiety and neurosis?

There is no recommended dose. The authors of the review of 87 studies from 2022 stated that formulating recommendations is currently not possible. Studies on situational anxiety used 300 mg as a single dose, while the series Shannon i in. (2019) averaged 25 mg per day.

How long does it take for CBD to start working for anxiety?

In studies on public speaking, the dose was administered 80 to 90 minutes before the test. With sublingual administration, the first sensations usually appear after 20-40 minutes. Assess the effect of daily use no earlier than after four weeks of symptom tracking.

Does CBD replace medications for neurosis?

No. Anxiety disorders are treated with cognitive-behavioral therapy and antidepressants and the WHO identifies these methods as fundamental. Discontinuing a psychiatric medication without consultation risks a relapse of symptoms. CBD can at most be an adjunct that the doctor is aware of.

Does CBD cause addiction with long-term use?

Raport WHO Expert Committee on Drug Dependence (2018) states that in humans, CBD does not show effects indicating potential for abuse or dependence, and the product is usually well tolerated. However, the data mainly comes from short observation periods.

Can CBD be combined with antidepressants?

Only after talking to a doctor. CBD inhibits CYP3A4 and CYP2C19, so it may raise the levels of psychiatric medications. Geffrey i in. (Epilepsia, 2015) they measured an increase in clobazam concentration by an average of 60%. Symptoms of drug overdose can then be confused with the effects of CBD.

Aktualny asortyment znajdziesz w kategorii hemp oils, and stock levels change continuously.

This article is for informational and educational purposes and does not constitute medical advice. Before starting to use cannabis or CBD for therapeutic purposes, consult a doctor, especially if you are taking other medications, are pregnant, or breastfeeding.

Author: Michał Waluk · Opublikowano: 2026-06-22 · Aktualizacja: 2026-08-07